Tuesday December 19, 2017 03:35

Heathcare Press Release : 24 Jul 2017

EMA#s CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Heathcare—24 Jul 17

- If approved, avelumab could be the first immunotherapy treatment indicated for this rare and aggressive skin cancer in the EU - Decision by the EC is expected in the third quarter of 2017 Merck and Pfizer Inc. (NYSE: PFE) today announced that the